Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, United States.
Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Rev Esp Cardiol (Engl Ed). 2022 Oct;75(10):786-796. doi: 10.1016/j.rec.2022.01.004. Epub 2022 Mar 3.
The index of microcirculatory resistance (IMR) measured after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) is associated with microvascular obstruction (MVO) and adverse clinical events. To evaluate MVO after successful primary PCI for STEMI without pressure wires or hyperemic agents, we investigated the feasibility and usefulness of functional angiography-derived IMR (angio-IMR).
The current study included a total of 285 STEMI patients who underwent primary PCI and cardiac magnetic resonance (CMR). Angio-IMR of the culprit vessel after successful primary PCI was calculated using commercial software. MVO, infarct size, and myocardial salvage index were assessed using CMR, which was obtained a median of 3.0 days [interquartile range, 3.0-5.0] after primary PCI.
Among the total population, 154 patients (54.0%) showed elevated angio-IMR (> 40 U) in the culprit vessel. MVO was significantly more prevalent in patients with angio-IMR> 40 U than in those with angio-IMR ≤ 40 U (88.3% vs 32.1%, P <.001). Infarct size, extent of MVO, and area at risk were significantly larger in patients with angio-IMR> 40 U than in those with angio-IMR ≤ 40 U (P <.001 for all). Angio-IMR showed a significantly higher discriminatory ability for the presence of MVO than thrombolysis in myocardial infarction flow grade or myocardial blush grade (area under the curve: 0.821, 0.504, and 0.496, respectively, P <.001).
Angio-IMR was significantly associated with CMR-derived infarct size, extent of MVO, and area at risk. An elevated angio-IMR (> 40 U) after primary PCI for STEMI was highly predictive of the presence of MVO in CMR. This trial was registered at ClnicalTrialsgov (Identifier: NCT04828681).
ST 段抬高型心肌梗死(STEMI)患者行直接经皮冠状动脉介入治疗(PCI)后测量的微循环阻力指数(IMR)与微血管阻塞(MVO)和不良临床事件相关。为了评估无压力导丝或充血剂的成功直接 PCI 后 STEMI 的 MVO,我们研究了功能血管造影衍生的 IMR(血管造影-IMR)的可行性和实用性。
本研究共纳入 285 例接受直接 PCI 和心脏磁共振(CMR)的 STEMI 患者。在成功直接 PCI 后,使用商业软件计算罪犯血管的血管造影-IMR。CMR 评估 MVO、梗死面积和心肌挽救指数,CMR 在直接 PCI 后中位时间 3.0 天[四分位间距,3.0-5.0]获得。
在总人群中,154 例患者(54.0%)的罪犯血管血管造影-IMR 升高(>40U)。血管造影-IMR>40U 的患者 MVO 明显更为常见,而血管造影-IMR≤40U 的患者则无(88.3%比 32.1%,P<0.001)。血管造影-IMR>40U 的患者梗死面积、MVO 程度和危险区面积明显大于血管造影-IMR≤40U 的患者(所有 P<0.001)。血管造影-IMR 对 MVO 的存在具有显著更高的判别能力,优于心肌梗死溶栓治疗血流分级或心肌灌注分级(曲线下面积:0.821、0.504 和 0.496,均 P<0.001)。
血管造影-IMR 与 CMR 衍生的梗死面积、MVO 程度和危险区显著相关。STEMI 患者直接 PCI 后血管造影-IMR(>40U)升高高度预测 CMR 中的 MVO 存在。本试验在 ClnicalTrials.gov 注册(标识符:NCT04828681)。